LAVA Therapeutics (LVTX) Stock Chart & Stock Price History $1.09 -0.02 (-1.80%) Closing price 03:47 PM EasternExtended Trading$1.08 -0.01 (-0.46%) As of 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LAVA Therapeutics Stock Price Performance 5 Day Performance-6.03%1 Month Performance-19.26%3 Month Performance+11.70%6 Month Performance-31.88%Year-To-Date Performance+14.62%1 Year Performance-64.14% Receive LVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address LVTX Stock Chart for Thursday, April, 10, 2025 LVTX Chart by TradingViewRemove Ads LAVA Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/09/2025$1.13$1.11-1.77%$1.15$1.0670,631 shs$29.20 million04/09/2025$1.13$1.11-1.77%$1.15$1.0670,631 shs$29.20 million04/08/2025$1.14$1.13-0.88%$1.20$1.0355,983 shs$29.73 million04/08/2025$1.14$1.13-0.88%$1.20$1.0355,983 shs$29.73 million04/07/2025$1.16$1.14-1.72%$1.15$1.1175,122 shs$29.99 million04/04/2025$1.18$1.16-1.69%$1.20$1.1097,795 shs$30.51 million04/03/2025$1.27$1.18-7.09%$1.25$1.16138,147 shs$31.03 million04/02/2025$1.25$1.27+1.60%$1.29$1.236,438 shs$33.40 million04/01/2025$1.27$1.25-1.57%$1.28$1.2347,869 shs$32.87 million03/31/2025$1.29$1.27-1.55%$1.30$1.2046,660 shs$33.40 million Get the Latest News and Ratings for LVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/28/2025$1.30$1.29-0.77%$1.36$1.2843,333 shs$33.92 million03/27/2025$1.28$1.30+1.96%$1.32$1.2023,739 shs$34.19 million03/26/2025$1.29$1.28-1.16%$1.30$1.2531,893 shs$33.53 million03/25/2025$1.30$1.29-0.77%$1.34$1.21126,352 shs$33.92 million03/24/2025$1.30$1.30$1.34$1.2743,059 shs$34.19 million03/21/2025$1.30$1.30$1.32$1.2422,117 shs$34.19 million03/20/2025$1.32$1.30-1.52%$1.33$1.2585,617 shs$34.19 million03/19/2025$1.29$1.32+2.33%$1.34$1.2326,808 shs$34.71 million03/18/2025$1.31$1.29-1.53%$1.34$1.2641,629 shs$33.92 million03/17/2025$1.30$1.31+0.77%$1.32$1.2928,357 shs$34.45 million03/14/2025$1.33$1.30-2.26%$1.35$1.2917,801 shs$34.18 million03/13/2025$1.35$1.33-1.48%$1.37$1.316,631 shs$34.96 million03/12/2025$1.35$1.35$1.37$1.3224,701 shs$35.49 million03/11/2025$1.35$1.35$1.37$1.3258,727 shs$35.49 million03/10/2025$1.44$1.35-6.25%$1.42$1.3552,068 shs$35.49 million Related Companies Larimar Therapeutics Stock Price Chart Neurogene Stock Price Chart scPharmaceuticals Stock Price Chart Organigram Stock Price Chart ADC Therapeutics Stock Price Chart Kodiak Sciences Stock Price Chart Tonix Pharmaceuticals Stock Price Chart Compugen Stock Price Chart Nkarta Stock Price Chart Cybin Stock Price Chart Receive LVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LVTX) was last updated on 4/10/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredOil Surge Predicted... But Are You Ready?Do you own oil and gas stocks? Or are you thinking about buying some? But it's NOT oil stocks, futures, or ...The Oxford Club | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share LAVA Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LVTX Stock Free LVTX Stock Alerts